ShuntCheck-Micro-Pumper Pediatric Clinical Outcomes Study

Status unconfirmed · Phase 4

Conditions studied: Suspected CSF Shunt Obstruction

In brief

Primary objective is to demonstrate that data collected from ShuntCheck-Micro-Pumper (SCMP) testing results can be used in conjunction with imaging to diagnose shunt patency or obstruction in pediatric/adolescent subjects presenting to an Emergency Department or Neurosurgery Clinic (ED/NC). SCMP results and SCMP results combined with other diagnostic methods, including the Attending Physician's and the Neurosurgeon's clinical judgment will be compared to clinical outcomes within 7 days of ED/NC visit - either shunt obstruction confirmed during shunt revision surgery or shunt patency confirmed by no surgery or patency confirmed in surgery.

Key facts

Study ID

NCT01881711

Run by

NeuroDx Development

People needed

400

Starts

2013-05-01

Expected to finish

2015-09-01

Last updated by the study team

2015-06-23

Who can join

Age: 3 and older, up to 29. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males or females, older than 35 months and less than 20 years of age.
• Parent/guardian or alert subject (age 18 or over) capable of giving consent; subject less than 18 and of assent age must give assent to participate if appropriate and required by the institution. If the subjects are incapable of giving assent, then only parent/guardian consent is required.
• Possess an unambiguously identifiable chronically indwelling ventricular shunt which crosses the clavicle.
• Suspicion of shunt obstruction is great enough to warrant the performance of any diagnostic test for this condition
• Will be available for follow-up for up to 7 days

You may not qualify if…

• Inability or unwillingness of the parent/guardian or alert subject to give informed consent/assent (when appropriate) as required by the Institutional Review Board.
• Presence of multiple shunts or known non-functioning shunts crossing the clavicle.
• Evaluating staff rule out shunt obstruction on the basis of a physical/clinical examination.
• SCMP test would interfere with emergent subject care or if the subject is scheduled to go the OR in short order.
• Presence of an interfering open wound or edema over the shunt.
• Likelihood, in the judgment of the investigator, of the subject being lost to follow-up as a result of subject unavailability or clinical outcome being unobtainable.
• Any other condition that would preclude or bias the results of the study according to the judgment of the investigator.
• Judgment of the investigator that participation in the study will interfere with, or be detrimental to, administration of optimal health-care to the subject.

Where it is running

• A I dePont Hospital for Children — Wilmington, Delaware, United States (enrolling)
• Children's National Medical Center — Washington D.C., District of Columbia, United States (enrolling)
• University of Chicago Comer Children's Hospital — Chicago, Illinois, United States (enrolling)
• Johns Hopkins Hospital — Baltimore, Maryland, United States (enrolling)
• Boston Children's Hospital — Boston, Massachusetts, United States (enrolling)
• Stony Brook Medical Center — Stony Brook, New York, United States (enrolling)
• Nationwide Children's Hospital — Columbus, Ohio, United States (enrolling)
• Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States (enrolling)
• Children's Hospital of Pittsburgh — Pittsburgh, Pennsylvania, United States (enrolling)
• Rhode Island Hospital — Providence, Rhode Island, United States (enrolling)
• University of Texas-Houston/Children's Memorial Hermann Hospital — Houston, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.